MeSH tree: C15.378.420.155
In most states, Medicaid eligibility rules shift at age 19, when individuals transition from child to adult classification. A new study led by the University of Chicago finds that this policy threshold coincides with a sharp ...
Feb 19, 2026
0
7
A new breakthrough study led by researchers at the University of Minnesota Twin Cities could explain why patients with the same genetic sickle cell mutation experience different levels of pain, organ damage, and response ...
Feb 10, 2026
0
16
Engineers at Stanford University have developed a high-efficiency, battery/solar-operated, autonomous microscope with integrated artificial intelligence that automatically diagnoses malaria in blood smears—a previously tedious ...
Feb 10, 2026
0
17
More children with medically complex conditions are surviving into adulthood, but researchers have had limited visibility into how these conditions influence adult hospital care. Young adults with complex chronic childhood-onset ...
Jan 28, 2026
0
13
Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting friends. It was a contrast to how Cole, 18, spent part of the 2024 holiday season. She was in the hospital—a ...
Jan 26, 2026
0
10
A new, fast and easy test could revolutionize blood transfusions, giving blood centers and hospitals a reliable way to monitor the quality of red blood cells after they sit for weeks in storage.
Jan 21, 2026
0
16
Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international research group led by the ...
Jan 15, 2026
0
9
Iron overload is prevalent among adults with sickle cell disease (SCD), according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 6 to 9 in Orlando, Florida.
Dec 10, 2025
0
9
Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease symptoms and low rates of severe side effects or complications years after their procedure, according ...
Dec 6, 2025
0
11
A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers lessons learned to inform best practices as manufacturers and medical centers prepare to meet growing ...
Dec 6, 2025
0
15
